OptimizeRx Corp
OPRX12.480USD
-0.280-2.19%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
232.03MMarket Cap
2888.89P/E TTM
More Details of OptimizeRx Corp Company
OptimizeRx Corporation is a healthcare technology company. The Company’s platform combines artificial intelligence (AI)-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. Its DAAP generates dynamic audiences with predictive analytics via machine learning methods. MNT creates consumer audiences using a privacy-first process. Its principal solutions include Audience Development: DAAP and MNT, Audience Profiling: Profiler, Audience Activation and Media Execution, Pharmacy Alerts, and Financial Messaging. Its Financial Messaging provides prescribers visibility to branded copay offers for patients directly within their electronic health record (EHR) systems and electronic prescribing (ERx) platforms. Its platform consists of a unified data intelligence technology stack, multiple cloud-based data warehouses, and in-house applications and application programming interface layers.
OptimizeRx Corp Info
Ticker SymbolOPRX
Company nameOptimizeRx Corp
IPO dateMay 18, 2005
CEOSilvestro (Stephen L)
Number of employees106
Security typeOrdinary Share
Fiscal year-endMay 18
Address260 Charles Street
CityWALTHAM
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code02453
Phone12486516558
Websitehttps://www.optimizerx.com/
Ticker SymbolOPRX
IPO dateMay 18, 2005
CEOSilvestro (Stephen L)
Company Executives of OptimizeRx Corp
Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%
Mr. Gregory D. (Greg) Wasson
Mr. Gregory D. (Greg) Wasson
Independent Director
Independent Director
43.90K
+29.00%
Mr. Patrick D. (Pat) Spangler
Mr. Patrick D. (Pat) Spangler
Independent Director
Independent Director
30.93K
-26.45%
Ms. Catherine M. Klema
Ms. Catherine M. Klema
Independent Director
Independent Director
14.98K
+193.15%
Mr. Brendan Merrell
Mr. Brendan Merrell
Chief Operating Officer
Chief Operating Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. James (Jim) Lang
Mr. James (Jim) Lang
Independent Director
Independent Director
386.03K
+2.62%
Mr. Stephen L. (Steve) Silvestro
Mr. Stephen L. (Steve) Silvestro
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
139.76K
+3.73%
Ms. Theresa Greco
Ms. Theresa Greco
Chief Commercial Officer
Chief Commercial Officer
76.86K
-2.16%
Mr. Edward (Ed) Stelmakh
Mr. Edward (Ed) Stelmakh
Chief Financial & Strategic Officer
Chief Financial & Strategic Officer
74.49K
+19.62%
Mr. Doug Besch
Mr. Doug Besch
Chief Product Officer and Chief Technology Officer
Chief Product Officer and Chief Technology Officer
69.57K
+3.48%
Mr. Andy D'Silva
Mr. Andy D'Silva
Chief Business Officer
Chief Business Officer
46.31K
-2.54%
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sun, Nov 16
Updated: Sun, Nov 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
Other
69.49%
Shareholders
Shareholders
Proportion
Whetstone Capital Advisors, LLC
8.09%
Weintraub (Michael)
7.43%
The Vanguard Group, Inc.
5.68%
BlackRock Institutional Trust Company, N.A.
5.67%
Royce Investment Partners
3.63%
Other
69.49%
Shareholder Types
Shareholders
Proportion
Investment Advisor
34.87%
Investment Advisor/Hedge Fund
22.55%
Individual Investor
16.38%
Hedge Fund
12.09%
Research Firm
4.75%
Pension Fund
0.78%
Bank and Trust
0.14%
Insurance Company
0.04%
Other
8.40%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
268
13.52M
72.70%
-5.62M
2025Q2
261
14.95M
80.84%
-7.34M
2025Q1
267
15.34M
83.16%
-6.19M
2024Q4
295
14.49M
78.68%
-4.45M
2024Q3
303
15.96M
87.07%
-2.38M
2024Q2
340
16.48M
89.93%
-3.43M
2024Q1
347
15.94M
87.64%
-3.60M
2023Q4
378
15.63M
86.21%
-4.61M
2023Q3
399
14.49M
86.61%
-5.94M
2023Q2
406
14.23M
85.34%
-7.19M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Whetstone Capital Advisors, LLC
1.51M
8.12%
--
--
Jun 30, 2025
Weintraub (Michael)
1.38M
7.46%
--
--
Apr 29, 2025
The Vanguard Group, Inc.
920.88K
4.96%
-963.00
-0.10%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.09M
5.89%
-72.63K
-6.23%
Jun 30, 2025
Royce Investment Partners
790.64K
4.26%
-203.66K
-20.48%
Jun 30, 2025
Kennedy Capital Management LLC
472.47K
2.54%
-5.93K
-1.24%
Jun 30, 2025
William Blair & Company, L.L.C. (Research)
628.93K
3.39%
-2.10K
-0.33%
Jun 30, 2025
Rice Hall James & Associates, LLC
607.56K
3.27%
+31.39K
+5.45%
Jun 30, 2025
Febbo (William J)
530.85K
2.86%
-83.11K
-13.54%
Apr 29, 2025
Parkman Healthcare Partners LLC
507.42K
2.73%
+32.42K
+6.83%
Jun 30, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
AAM Sawgrass US Small Cap Quality Growth ETF
1.37%
Janus Henderson Small Cap Growth Alpha ETF
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.57%
Even Herd Long Short ETF
0.19%
Vanguard US Multifactor ETF
0.1%
Vanguard US Momentum Factor ETF
0.1%
iShares Micro-Cap ETF
0.06%
Principal U.S. Small-Cap ETF
0.05%
Avantis US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.02%
View more
AAM Sawgrass US Small Cap Quality Growth ETF
Proportion1.37%
Janus Henderson Small Cap Growth Alpha ETF
Proportion0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion0.57%
Even Herd Long Short ETF
Proportion0.19%
Vanguard US Multifactor ETF
Proportion0.1%
Vanguard US Momentum Factor ETF
Proportion0.1%
iShares Micro-Cap ETF
Proportion0.06%
Principal U.S. Small-Cap ETF
Proportion0.05%
Avantis US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 Growth ETF
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
FAQs
Who are the top five shareholders of OptimizeRx Corp?
The top five shareholders of OptimizeRx Corp are:
Whetstone Capital Advisors, LLC holds 1.51M shares, accounting for 8.12% of the total shares.
Weintraub (Michael) holds 1.38M shares, accounting for 7.46% of the total shares.
The Vanguard Group, Inc. holds 920.88K shares, accounting for 4.96% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.09M shares, accounting for 5.89% of the total shares.
Royce Investment Partners holds 790.64K shares, accounting for 4.26% of the total shares.
Whetstone Capital Advisors, LLC holds 1.51M shares, accounting for 8.12% of the total shares.
Weintraub (Michael) holds 1.38M shares, accounting for 7.46% of the total shares.
The Vanguard Group, Inc. holds 920.88K shares, accounting for 4.96% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 1.09M shares, accounting for 5.89% of the total shares.
Royce Investment Partners holds 790.64K shares, accounting for 4.26% of the total shares.
What are the top three shareholder types of OptimizeRx Corp?
The top three shareholder types of OptimizeRx Corp are:
Whetstone Capital Advisors, LLC
Weintraub (Michael)
The Vanguard Group, Inc.
Whetstone Capital Advisors, LLC
Weintraub (Michael)
The Vanguard Group, Inc.
How many institutions hold shares of OptimizeRx Corp (OPRX)?
As of 2025Q3, 268 institutions hold shares of OptimizeRx Corp, with a combined market value of approximately 13.52M, accounting for 72.70% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -8.14%.
What is the biggest source of revenue for OptimizeRx Corp?
In --, the -- business generated the highest revenue for OptimizeRx Corp, amounting to -- and accounting for --% of total revenue.
